Literature DB >> 25213782

Pulmonary embolism with haemorrhagic pericardial effusion and tamponade: a clinical dilemma.

Charlotte Thomas1, Katie Lane1, Maurizio Cecconi1.   

Abstract

The synchronous presentation of a patient with pulmonary embolism (PE) and haemorrhagic cardiac tamponade is uncommon and presents a therapeutic dilemma. Both conditions can be life-threatening and require opposing management strategies. The authors report a 50-year-old woman who presented with abdominal symptoms and subsequent rapid development of dyspnoea and cardiogenic shock. Investigations demonstrated bilateral segmental PEs and a large pericardial effusion causing cardiac tamponade. This large blood-stained effusion was drained urgently. She developed acute kidney injury and acute hepatic injury with synthetic failure. She was initially deemed unsuitable for anticoagulation so an inferior vena cava filter was placed to minimise risk of further PE. When no early re-accumulation of pericardial fluid occurred, a heparin infusion was started to treat the PEs. Pericardial fluid cytology was suggestive of metastatic carcinoma, with the immunophenotype most consistent with metastatic non-small cell lung cancer. She was subsequently treated with the tyrosine kinase inhibitor, erlotinib. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25213782      PMCID: PMC4166124          DOI: 10.1136/bcr-2013-202285

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.

Authors: 
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

2.  Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.

Authors:  D W BARRITT; S C JORDAN
Journal:  Lancet       Date:  1960-06-18       Impact factor: 79.321

3.  Evaluation of coagulation abnormalities in acute liver failure.

Authors:  Banwari Agarwal; Gavin Wright; Alex Gatt; Anne Riddell; Vishwaraj Vemala; Susan Mallett; Pratima Chowdary; Andrew Davenport; Rajiv Jalan; Andrew Burroughs
Journal:  J Hepatol       Date:  2012-06-23       Impact factor: 25.083

4.  Long-term follow-up of idiopathic chronic pericardial effusion.

Authors:  J Sagristà-Sauleda; J Angel; G Permanyer-Miralda; J Soler-Soler
Journal:  N Engl J Med       Date:  1999-12-30       Impact factor: 91.245

5.  Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.

Authors:  J A Heit; M D Silverstein; D N Mohr; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  2000-03-27

6.  Radiological (scintigraphic) evaluation of patients with suspected pulmonary thromboembolism.

Authors:  D R Biello
Journal:  JAMA       Date:  1987-06-19       Impact factor: 56.272

7.  Simultaneously diagnosed pulmonary thromboembolism and hemopericardium in a man with thoracic spinal cord injury.

Authors:  Jae-Young Han; Hyo-Jeong Seon; In-Sung Choi; Youngkeun Ahn; Myung-Ho Jeong; Sam-Gyu Lee
Journal:  J Spinal Cord Med       Date:  2012-05       Impact factor: 1.985

Review 8.  Risk factors for venous thromboembolism.

Authors:  Frederick A Anderson; Frederick A Spencer
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

9.  Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).

Authors:  Adam Torbicki; Arnaud Perrier; Stavros Konstantinides; Giancarlo Agnelli; Nazzareno Galiè; Piotr Pruszczyk; Frank Bengel; Adrian J B Brady; Daniel Ferreira; Uwe Janssens; Walter Klepetko; Eckhard Mayer; Martine Remy-Jardin; Jean-Pierre Bassand
Journal:  Eur Heart J       Date:  2008-08-30       Impact factor: 29.983

  9 in total
  1 in total

1.  Management of cardiac tamponade during catheter-directed thrombolysis of saddle pulmonary embolism: A clinical dilemma.

Authors:  Hanzhou Li; Serena Jen; Shvetank Agarwal; Eran Rotem
Journal:  Lung India       Date:  2018 Jul-Aug
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.